You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

SODIUM NITROPRUSSIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for sodium nitroprusside and what is the scope of freedom to operate?

Sodium nitroprusside is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Vpna, Abraxis Pharm, Amneal, Amphastar Pharms Inc, Avet Lifesciences, Baxter Hlthcare, Be Pharms, Caplin, Chartwell Rx, Cipla, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Micro Labs, Mylan Labs Ltd, Nexus, Norvium Bioscience, Sagent Pharms Inc, Slate Run Pharma, Somerset Theraps Llc, Sun Pharm, Teva Parenteral, Xiromed, and Exela Pharma, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for sodium nitroprusside. Sixteen suppliers are listed for this compound.

Summary for SODIUM NITROPRUSSIDE
Drug Prices for SODIUM NITROPRUSSIDE

See drug prices for SODIUM NITROPRUSSIDE

Recent Clinical Trials for SODIUM NITROPRUSSIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EgymedicalpediaEarly Phase 1
Tanta UniversityN/A
Kafrelsheikh UniversityN/A

See all SODIUM NITROPRUSSIDE clinical trials

Pharmacology for SODIUM NITROPRUSSIDE
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for SODIUM NITROPRUSSIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Be Pharms SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 214971-001 Jul 12, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Exela Pharma NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-003 Jul 13, 2018 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Exela Pharma NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-002 Dec 7, 2017 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xiromed SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 211277-001 Oct 29, 2020 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 211934-001 Dec 10, 2020 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209352-001 Dec 8, 2017 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 070566-001 Jun 9, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.